Abstract
Acute Myeloid Leukemia (AML) is an aggressive malignant neoplasm that leads to bone marrow failure and has a high potential for infiltration into other organs, often proving fatal if left untreated. AML accounts for approximately 1.9% of cancer-related deaths. Furthermore, data from the same institute indicate that this tumor predominantly affects middle-aged adults, with over 2/3 of case…